Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Video capillaroscopy
- Analysis with capillaroscopy (1)
- Analysis with capillaroscopy (2)
- Analysis with capillaroscopy (3)
- Analysis with capillaroscopy (4)
- Analysis with capillaroscopy (5)
- Analysis with capillaroscopy (6)
- Lens ability to evaluate vessel network
- Limit of detection
- Nailfold vascular bed
- Analysis of healthy subject
- Raynaud's phenomenon and role of capillaroscopy
- Mechanisms contributing to RP
- Physical features of Raynaud's phenomenon
- Normal response to cold challenge in PRP
- Acute phase of primary Raynaud's phenomenon
- RP response to cold challenge in SRP
- Scleroderma
- Patophysiology of scleroderma
- Lesions observed in the nailfolds
- Lesions observed in the skin
- Early clinical signs
- Classification of the SSc patterns
- Infiltration of immune cells around vessels
- Megacapillaries
- Megacapillaries and edema
- Microhaemorrages
- Capillaroscopic patterns in SSc - early phase
- Changes in capillaries
- Capillaroscopic patterns in SSc - active phase
- Production of extra-cellular matrix proteins
- Necrotic lesions on the skin
- Fibrosis
- Neoangiogenesis
- Fibrosis and neoangiogenesis
- Late pattern - loss of capillaries
- Capillaroscopic patterns in SSc - late phase
- Capillaroscopic patterns in scleroderma: summary
- Dermatomyiositis
- Dermatomyiositis - capillary abnormalities
- Systemic lupus erythematosus
- SLE - capillary abnormalities
- Antiphospholipid syndrome
- APL syndrome - capillary abnormalities
- Impaired cerebral blood flow in SSc patients
- Blood flow in the brain in slceroderma
- Cerebral hypoperfusion in SSc patients
- Cerebral blood flow in SSc patients
- Cyclosporin treatment of SSc
- Capillaroscopy during cyclosporin treatment
- Endothelin contributes to RP
- High levels of ET are present in RP
- High levels of ET are present in late stage of SSc
- Endothelin levels in the different patterns
- Fibronectin synthesis
- Endothelin activates damage progression
- Acknowledgments
- 1st European course of capillaroscopy
- 2nd European course of capillaroscopy
Topics Covered
- Materials and methods for the correct employment of the video capillaroscopy
- The Raynaud's phenomenon and the role of capillaroscopy
- The scleroderma pattern today
- Scleroderma pattern and pathophysiological significance
- Frequent patterns in dermatomyositis, systemic lupus erythematosus and antiphospholipid syndromes
- Correlations between the capillaroscopic patterns and clinical and laboratory findings
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Cutolo, M. (2007, October 1). Capillaroscopy in autoimmune rheumatic diseases [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/LXAW6005.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Maurizio Cutolo has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.